Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high-fat diet-fed rats through AMP-activated protein kinase signaling

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 205-210

  Kong, Dexian ^a   Song, Guangyao ^a   Wang, Chao ^b   Ma, Huijuan ^b   Ren, Luping ^b   Nie, Qian ^b   Zhang, Xuemei ^b   Gan, Kexin ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

AMP activated protein kinase; Glucose transporter 4; Insulin resistance; Mitofusin 2

Indexed keywords

ADENOVIRUS VECTOR; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MITOFUSIN 2;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; FATTY ACIDS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN; MALE; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 84878923118     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1457     Document Type: Article

References (25)

1. Bach D, Naon D, Pich S, et al: Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54: 2685-2693, 2005. (Pubitemid 41233591)
2. van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1: 368-371, 1992.
3. Zorzano A, Liesa M and Palacin M: Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch Physiol Biochem 115: 1-12, 2009.
4. Hoeks J and Schrauwen P: Muscle mitochondria and insulin resistance: a human perspective. Trends Endocrinol Metab 23: 444-450, 2012.
5. Bach D, Pich S, Soriano FX, et al: Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190-17197, 2003. (Pubitemid 36799599)
6. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE and Chan DC: Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160: 189-200, 2003. (Pubitemid 36254953)
7. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M and Zorzano A: Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha and mitofusin 2. Diabetes 55: 1783-1791, 2006. (Pubitemid 44324133)
8. Sebastián D, Hernández-Alvarez MI, Segalés J, et al: Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA 109: 5523-5528, 2012.
9. Pich S, Bach D, Briones P, et al: The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14: 1405-1415, 2005. (Pubitemid 40823451)
10. McConell GK and Wadley GD: Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clin Exp Pharmacol Physiol 35: 1488-1492, 2008.
11. Zhao HL, Liu LZ, Sui Y, et al: Fatty acids inhibit insulin-mediated glucose transport associated with actin remodeling in rat L6 muscle cells. Acta Diabetol 47: 331-339, 2010.
12. Jaiswal N, Yadav PP, Maurya R, Srivastava AK and Tamrakar AK: Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner. Eur J Pharmacol 670: 22-28, 2011.
13. Kim JY, Jo KJ, Kim BJ, Baik HW and Lee SK: 17β-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1 adipocytes. Int J Mol Med 30: 979-985, 2012.
14. Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F and Weng JP: Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol 45: 167-178, 2008.
15. Iglesias MA, Ye JM, Frangioudakis G, et al: AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51: 2886-2894, 2002.
16. Sato T, Man ZW, Toide K and Asahi Y: Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus. FEBS Lett 407: 329-332, 1997. (Pubitemid 27199453)
17. Wang ZQ, Zhang XH, Yu Y, et al: Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem 22: 1064-1073, 2011.
18. Hernández-Alvarez MI, Thabit H, Burns N, et al: Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 33: 645-651, 2010.
19. Mingrone G, Manco M, Calvani M, Castagneto M, Naon D and Zorzano A: Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia 48: 2108-2114, 2005. (Pubitemid 41416923)
20. Chen X and Xu Y: Liver-specific reduction of Mfn2 protein by RNAi results in impaired glycometabolism and lipid homeostasis in BALB/c mice. J Huazhong Univ Sci Technolog Med Sci 29: 689-696, 2009.
21. Mingrone G, Rosa G, Di Rocco P, et al: Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord 26: 1165-1172, 2002.
22. Yu H, Guo Y, Mi L, Wang X, Li L and Gao W: Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy. J Cardiovasc Pharmacol Ther 16: 205-211, 2011.
23. Guo YH, Chen K, Gao W, et al: Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun 363: 411-417, 2007. (Pubitemid 47496120)
24. Lugus JJ, Ngoh GA, Bachschmid MM and Walsh K: Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells. J Mol Cell Cardiol 51: 885-893, 2011.
25. Wan-Xin T, Tian-Lei C, Ben W, Wei-Hua W and Ping F: Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells. J Nephrol 25: 1023-1030, 2012.